Galena Biopharma: A Twist on The Classic “Pump & Dump”
So here we had a situation where Plaintiffs and the
Rosen Law Firm Appointed Lead Counsel in Latch, Inc. Securities Litigation
- January 18, 2023
Click here to learn more about The Rosen Law Firm’s representation of investors in securities litigation: for pension funds, foundations, endowments, family offices, hedge funds, individuals.
While selective about commencing litigation, we are committed to expanding relevant laws for the benefit of shareholders. We undertake in-depth analysis of potential claims and damages before recommending that our clients initiate litigation or seek to become lead plaintiff in a case. Click here to find out more.
If you have heard about a suit being filed regarding one of the companies in your portfolio, click here.
Receive “Letter of The Law,” our regular newsletter on securities litigation affecting institutional and individual investors.
“Letter Of The Law” Newsletter sponsored by: The Rosen Law Firm, 275 Madison Avenue, 40th Floor. New York, New York, 10016
Fiat Chrysler Cheats Emissions Tests & Investors
The Rosen Law Firm recovered millions for investors who purchased
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Correvio Pharma Corp. common stock – CORV
If you purchased Blue Apron Holdings, Inc. (“Blue Apron”) Class
